What was Predilife SA’s price range in the past 12 months?
Predilife SA lowest stock price was €0.64 and its highest was €4.00 in the past 12 months.
What is Predilife SA’s market cap?
Predilife SA’s market cap is €3.35M.
When is Predilife SA’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Predilife SA overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Predilife SA pay dividends?
Predilife SA does not currently pay dividends.
What is Predilife SA’s EPS estimate?
Predilife SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Predilife SA have?
Predilife SA has 3,952,233 shares outstanding.
Which hedge fund is a major shareholder of Predilife SA?
Currently, no hedge funds are holding shares in FR:ALPRE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Predilife SA
Founded in 2004 and headquartered in Villejuif, France, Predilife S.A. specializes in devising and commercializing sophisticated medical technologies and analytical models. The company's core offerings include preventative healthcare solutions and comprehensive breast screening tests. Among its notable products are MammoRisk, a diagnostic tool designed to forecast an individual's risk of developing breast cancer; DenSeeMammo, software for evaluating breast tissue density; and a specialized medical device developed for predicting prostate cancer risk.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Stephane Ragusa
Employees
21
Website
www.predilife.com
Address
39, Rue Camille Desmoulins, Villejuif, IF, 94805, FR